TABLE 4.
Antiviral and antimicrobial treatments
| Patient | COVID-19 directed therapy | Antimicrobial agents | Bacterial coinfection |
|---|---|---|---|
| 1 | none | None | |
| 2 | HCQ, azithro | None | |
| 3 | HCQ, azithro | Ceftriaxone | Enterococcus in urine |
| 4 | HCQ, azithro | Ceftriaxone | Klebsiella pneumonia in urine |
| 5 | HCQ, azithro | Ceftriaxone | |
| 6 | HCQ, azithro | Cefepime, vanco | |
| 7 | HCQ, azithro | Ceftriaxone, pip/tazo, vanco | |
| 8 | HCQ, azithro | pip/tazo, vanco | |
| 9 | HCQ, azithro | N/a | |
| 10 | HCQ, azithro | Levofloxacin, ceftriaxone | E. coli in urine |
Abbreviations: azithro, azithromycin; COVID-19, coronavirus disease 2019; HCQ, hydroxychloroquine; N/a, nonapplicable; pip/tazo, piperacillin tazobactam; vanco, vancomycin.